Bruker Corporation (BRKR | DoD: -2.21% | YTD: -43.36% | MidCap: 5.6B)

• Profile: Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions
• Stock Offering: Bruker Announces Public Offering of $600 Million of Mandatory Convertible Preferred Stock (Full Text)

STAAR Surgical Company (STAA | DoD: +1.39% | YTD: +15.10% | SmallCap: 858M)

• Profile: The global leader in vision correction technology
• Merger: STAAR Surgical Reiterates Compelling, Premium Cash Value Provided by Alcon Merger (Full Text)

Autonomix Medical, Inc. (AMIX | DoD: +10.71% | YTD: -63.20% | SmallCap: 4M)

• Profile: A medical device company focused on advancing precision nerve-targeted treatments
• Clinical: Autonomix Medical, Inc. Demonstrates Sustained Pain Reduction, Quality of Life Gains and 100% Zero Opioid Use in Longer-Term Post Hoc Analysis from PoC 1 Study (Full Text)

Biomerica, Inc. (BMRA | DoD: -4.15% | YTD: +23.76% | SmallCap: 9M)

• Profile: A biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide
• Regulatory: United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Test for Home Use (Full Text)

CareDx, Inc (CDNA | DoD: +1.39% | YTD: -35.64% | SmallCap: 957M)

• Profile: Engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers
• Regulatory: CareDx Issues Comment Letter on Draft LCD Policy (Full Text)

Envoy Medical, Inc. (COCH | DoD: +4.88% | YTD: -16.23% | SmallCap: 32M)

• Profile: A revolutionary hearing health company focused on fully implanted hearing devices
• Clinical: Envoy Medical Successfully Reaches Three-Month Follow-Up Milestone in Clinical Trial of the Acclaim Fully Implanted Cochlear Implant (Full Text)

Sight Sciences, Inc. (SGHT | DoD: -4.68% | YTD: +8.10% | SmallCap: 206M)

• Profile: An eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care
• Clinical: Sight Sciences Announces Recognition of the TearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO (Full Text)

Aethlon Medical, Inc. (AEMD | DoD: -12.30% | YTD: -74.38% | SmallCap: 6M)

• Profile: A medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases
• Patent: Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC) (Full Text)

Charles River Laboratories International, Inc. (CRL | DoD: -1.26% | YTD: -11.71% | MidCap: 6.8B)

• Profile: Provides drug discovery, non-clinical development, and safety testing services
• Collaboration: Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences (Full Text)

Illumina, Inc. (ILMN | DoD: -2.14% | YTD: -25.29% | MidCap: 12.9B)

• Profile: Provides sequencing- and array-based solutions for genetic and genomic analysis
• Product: Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development (Full Text)

Outset Medical, Inc. (OM | DoD: -1.22% | YTD: -21.71% | SmallCap: 316M)

• Profile: A medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis
• Collaboration: Northwest Kidney Centers and Outset Medical Announce Collaboration to Grow Home Hemodialysis (Full Text)

Pacific Biosciences of California, Inc. (PACB | DoD: -2.29% | YTD: -28.89% | SmallCap: 321M)

• Profile: Designs, develops, and manufactures sequencing solution to resolve genetically complex problems
• Partnership: PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow (Full Text)

Agilent Technologies, Inc. (A | DoD: -0.36% | YTD: -5.76% | LargeCap: 32.1B)

• Profile: Provider of application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide
• Event: Agilent to Showcase New Dako Omnis Family at European Congress of Pathology 2025 (Full Text)

BioSig Technologies, Inc. (BSGM | DoD: -1.05% | YTD: +237.86% | SmallCap: 178M)

• Profile: A medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal visualization
• Announcement: BioSig Technologies Supplements Clarification on Recent Schedule 14A Filing. Closing of Merger with Streamex Exchange Corporation Not Affected (Full Text)

LENSAR, Inc. (LNSR | DoD: +0.57% | YTD: +42.12% | SmallCap: 161M)

• Profile: A global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts
• Announcement: LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Full Text)

Nyxoah SA (NYXH | DoD: -5.45% | YTD: -34.73% | SmallCap: 291M)

• Profile: A medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA)
• Event: Nyxoah Announces Upcoming Investor Events (Full Text)

ProPhase Labs, Inc. (PRPH | DoD: -2.31% | YTD: -62.47% | SmallCap: 16M)

• Profile: Develops and commercializes novel drugs, dietary supplements, and compounds
• Event: ProPhase Labs Inc. to Participate in Renmark's Virtual Non-Deal Roadshow Series on Thursday, September 4, 2025 (Full Text)

Perspective Therapeutics, Inc. (CATX | DoD: -1.19% | YTD: +0.30% | SmallCap: 246M)

• Profile: Develops and commercializes precision targeted alpha therapies (TAT) to treat cancer
• Leadership Update: Perspective Therapeutics Appoints Maya Martinez-Davis to Board of Directors (Full Text)

Sanara MedTech Inc. (SMTI | DoD: +2.88% | YTD: +4.62% | SmallCap: 259M)

• Profile: A medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets
• Leadership Update: Sanara MedTech Inc. Announces Chief Executive Officer Transition (Full Text)

electroCore, Inc. (ECOR | DoD: -0.94% | YTD: -68.63% | SmallCap: 37M)

• Profile: A commercial-stage bioelectronic medicine and wellness company
• Leadership Update: electroCore Appoints Elena Bonfiglioli to Board of Directors (Full Text)